Correction: Conventional CD4+ T cells present bacterial antigens to induce cytotoxic and memory CD8+ T cell responses (Nature Communications (2017) DOI: 10.1038/s41467-017-01661-7);Conventional CD4+ T cells present bacterial antigens to induce cytotoxic and memory CD8+ T cell responses

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Cruz Adalia, Aránzazu ^a   Ramirez Santiago, Guillermo ^a,b   Osuna Pérez, Jesús ^a   Torres Torresano, Mónica ^a   Zorita, Virgina ^c   Martínez Riaño, Ana ^d   Boccasavia, Viola ^d   Borroto, Aldo ^d   Martínez Del Hoyo, Gloria ^c   Gozález Granado, José María ^c,e   Alarcón, Balbino ^d   Sánchez Madrid, Francisco ^f   Veiga, Esteban ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e Universidad Complutense   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; PROGRAMMED DEATH 1 RECEPTOR; PDCD1 PROTEIN, MOUSE;

ANTIGEN; BACTERIUM; CANCER; CELLS AND CELL COMPONENTS; GENE; GENE EXPRESSION; IMMUNE RESPONSE; INFECTIOUS DISEASE; MEMORY; PROTEIN; TOXICITY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNITY; IN VIVO STUDY; LISTERIOSIS; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MELANOMA; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SYNAPSE; ANIMAL; C57BL MOUSE; CELL CULTURE; CROSS PRESENTATION; CYTOTOXICITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL SYNAPSE; IMMUNOLOGY; PHAGOCYTOSIS; TRANSGENIC MOUSE;

BACTERIA (MICROORGANISMS);

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CROSS-PRIMING; CYTOTOXICITY, IMMUNOLOGIC; IMMUNOLOGIC MEMORY; IMMUNOLOGICAL SYNAPSES; MICE, INBRED C57BL; MICE, TRANSGENIC; PHAGOCYTOSIS; PROGRAMMED CELL DEATH 1 RECEPTOR;

EID: 85034414532     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-03074-6     Document Type: Erratum

References (61)

1. Vance, R. E., Eichberg, M. J., Portnoy, D. A. & Raulet, D. H. Listening to each other: Infectious disease and cancer immunology. Sci. Immunol. 2, eaai9339 (2017).
2. Neefjes, J. & Ovaa, H. A peptide's perspective on antigen presentation to the immune system. Nat. Chem. Biol. 9, 769-775 (2013).
3. Joffre, O. P., Segura, E., Savina, A. & Amigorena, S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12, 557-569 (2012).
4. Fehres, C. M., Unger, W. W. J., Garcia-Vallejo, J. J. & van Kooyk, Y. Understanding the biology of antigen cross-presentation for the design of vaccines against cancer. Front. Immunol. 5, 149 (2014).
5. Leiriao, P., del Fresno, C. & Ardavin, C. Monocytes as effector cells: Activated Ly-6Chigh mouse monocytes migrate to the lymph nodes through the lymph and cross-present antigens to CD8+ T cells. Eur. J. Immunol. 42, 2042-2051 (2012) .
6. Saito, T. & Batista, F. D. Immunological Synapse. XV,1-255 (Springer, 2010).
7. Lauvau, G., Boutet, M., Williams, T. M., Chin, S. S. & Chorro, L. Memory CD8 (+) T cells: Innate-like sensors and orchestrators of protection. Trends. Immunol. 37, 375-385 (2016).
8. Sabado, R. L., Balan, S. & Bhardwaj, N. Dendritic cell-based immunotherapy. Cell Res. 27,74-95 (2017).
9. Chen, D. S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 39,1-10 (2013).
10. D'Errico, G., Machado, H. L. & Sainz, B. A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet. Clin Transl Med 6, 3 (2017).
11. Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707-723 (2017).
12. Janssen, E. M. et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nat. Commun. 421, 852-856 (2003).
13. Shedlock, D. J. & Shen, H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300, 337-339 (2003).
14. Laidlaw, B. J., Craft, J. E. & Kaech, S. M. The multifaceted role of CD4(+) T cells in CD8(+) T cell memory. Nat. Rev. Immunol. 16, 102-111 (2016).
15. Bennett, S. R. et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nat. Commun. 393, 478-480 (1998).
16. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R. & Melief, C. J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nat. Commun. 393, 480-483 (1998).
17. Montfort, M. J., Bouwer, H. G. A., Wagner, C. R. & Hinrichs, D. J. The development of functional CD8 T cell memory after Listeria monocytogenes infection is not dependent on CD40. J. Immunol. 173, 4084-4090 (2004).
18. Hamilton, S. E., Tvinnereim, A. R. & Harty, J. T. Listeria monocytogenes infection overcomes the requirement for CD40 ligand in exogenous antigen presentation to CD8(+) T cells. J. Immunol. 167, 5603-5609 (2001).
19. Cruz-Adalia, A. et al. T cells kill bacteria captured by transinfection from dendritic cells and confer protection in mice. Cell Host Microbe. 15, 611-622 (2014).
20. Lanzavecchia, A., Roosnek, E., Gregory, T., Berman, P. & Abrignani, S. T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nat. Commun. 334, 530-532 (1988).
21. Barnaba, V., Watts, C., de Boer, M., Lane, P. & Lanzavecchia, A. Professional presentation of antigen by activated human T cells. Eur. J. Immunol. 24,71-75 (1994).
22. Klebanoff, C. A. et al. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl Acad. Sci. USA 102, 9571-9576 (2005).
23. Brockstedt, D. G. et al. Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc. Natl Acad. Sci. USA 101, 13832-13837 (2004).
24. Lyons, A. B., Blake, S. J. & Doherty, K. V. Flow cytometric analysis of cell division by dilution of CFSE and related dyes. Curr Protoc Cytom 9, Unit9.11 (2013) . Chapter.
25. Wetzel, S. A. & Parker, D. C. MHC transfer from APC to T cells following antigen recognition. Crit. Rev. Immunol. 26,1-21 (2006).
26. Dudziak, D. et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107-111 (2007).
27. Raghavan, M., Del Cid, N., Rizvi, S. M. & Peters, L. R. MHC class I assembly: out and about. Trends Immunol. 29, 436-443 (2008).
28. Lang, T. J., Nguyen, P., Peach, R., Gause, W. C. & Via, C. S. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J. Immunol. 168, 3786-3792 (2002).
29. Dustin, M. L. & Groves, J. T. Receptor signaling clusters in the immune synapse. Annu. Rev. Biophys. 41, 543-556 (2012).
30. Gomez, T. S. et al. Dynamin 2 regulates T cell activation by controlling actin polymerization at the immunological synapse. Nat. Immunol. 6, 261-270 (2005).
31. Calabia-Linares, C. et al. Endosomal clathrin drives actin accumulation at the immunological synapse. J. Cell Sci. 124, 820-830 (2011).
32. Lang, D. et al. Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nat. Commun. 433, 884-887 (2005).
33. Huster, K. M. et al. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc. Natl Acad. Sci. USA 101, 5610-5615 (2004).
34. Boettler, T. et al. Expression of the interleukin-7 receptor alpha chain (cd127) on virus-specific cd8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J. Virol. 80, 3532-3540 (2006).
35. Goldszmid, R. S. et al. TAP-1 indirectly regulates CD4+ T cell priming in toxoplasma gondii infection by controlling NK cell IFN-gamma production. J. Exp. Med. 204, 2591-2602 (2007).
36. Thale, C. & Kiderlen, A. F. Sources of interferon-gamma (IFN-gamma) in early immune response to Listeria monocytogenes. Immunobiology. 210, 673-683 (2005).
37. De Pascalis, R., Taylor, B. C. & Elkins, K. L. Diverse myeloid and lymphoid cell subpopulations produce gamma interferon during early innate immune responses to francisella tularensis live vaccine strain. Infect. Immun. 76, 4311-4321 (2008).
38. Bjorkdahl, O. et al. Characterization of CC-chemokine receptor 7 expression on murine T cells in lymphoid tissues. Immunology. 110, 170-179 (2003).
39. Raulet, D. H. MHC class I-deficient mice. Adv. Immunol. 55, 381-421 (1994).
40. Restifo, N. P., Dudley, M. E. & Rosenberg, S. A. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat. Rev. Immunol. 12, 269-281 (2012).
41. Overwijk, W. W. & Restifo, N. P. B16 as a mouse model for human melanoma. Curr. Protoc. Immunol. 20, Unit20.1 (2001). Chapter.
42. Bellone, M. et al. Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma. J. Immunol. 165, 2651-2656 (2000).
43. Borroto, A. et al. Relevance of Nck-CD3 epsilon interaction for T cell activation in vivo. J. Immunol. 192, 2042-2053 (2014).
44. Jung, S. et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity. 17, 211-220 (2002).
45. Cruz-Adalia, A. & Veiga, E. Close encounters of lymphoid cells and bacteria. Front. Immunol. 7, 405 (2016).
46. Hor, J. L. et al. Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4+ and CD8+ T cell activation to localized viral infection. Immunity. 43, 554-565 (2015).
47. Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nat. Commun. 480, 480-489 (2012).
48. Amezquita, R. A. & Kaech, S. M. Immunology: The chronicles of T-cell exhaustion. Nat. Commun. 543, 190-191, https://doi.org/10.1038/nature21508 (2017).
49. Wang, R.-F. & Wang, H. Y. Immune targets and neoantigens for cancer immunotherapy and precision medicine. Cell Res. 27,11-37 (2017).
50. Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348,69-74 (2015).
51. Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nat. Commun. 515, 577-581 (2014).
52. Mayordomo, J. I. et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1, 1297-1302 (1995).
53. Barnden, M. J., Allison, J., Heath, W. R. & Carbone, F. R. Defective TCR expression in transgenic mice constructed using cDNA-based alpha-and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76,34-40 (1998).
54. Clarke, S. R. et al. Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol. Cell Biol. 78, 110-117 (2000).
55. Hogquist, K. A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76,17-27 (1994).
56. Kaye, J. et al. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nat. Commun. 341, 746-749 (1989).
57. Martinez-Martin, N. et al. T cell receptor internalization from the immunological synapse is mediated by TC21 and RhoG GTPase-dependent phagocytosis. Immunity. 35, 208-222 (2011).
58. Medina, F. et al. Furin-processed antigens targeted to the secretory route elicit functional TAP1-/-CD8+ T lymphocytes in vivo. J. Immunol. 183, 4639-4647 (2009).
59. Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869-877 (1992).
60. Riedel, C. U. et al. Improved luciferase tagging system for listeria monocytogenes allows real-time monitoring in vivo and in vitro. Appl. Environ. Microbiol. 73, 3091-3094 (2007).
61. Cruz-Adalia, A., Ramirez-Santiago, G., Torres-Torresano, M., Garcia-Ferreras, R. & Veiga, E. T. Cells capture bacteria by transinfection from dendritic cells. J. Vis. Exp. e52976, https://doi.org/10.3791/52976 (2016).